Prokidney Corp. SEC filings PROK
Prokidney Corp. has 401 filings in SEC EDGAR's recent list, going back to Apr 21, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 18, 2025 | — |
| DEL AM | Filing | Nov 5, 2025 | — |
| 8-K12B/A | Filing | Jul 16, 2025 | Jul 1, 2025 |
| EFFECT | Filing | Jul 7, 2025 | — |
| EFFECT | Filing | Jul 7, 2025 | — |
| 8-K12B | Filing | Jul 3, 2025 | Jul 1, 2025 |
| EFFECT | Filing | Apr 28, 2025 | — |
| CORRESP | Letter to the SEC | Apr 24, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2025 | — |
| EFFECT | Filing | Nov 30, 2023 | — |
| CORRESP | Letter to the SEC | Nov 28, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| EFFECT | Filing | Aug 21, 2023 | — |
| EFFECT | Filing | Apr 20, 2023 | — |
| EFFECT | Filing | Sep 8, 2022 | — |
| CORRESP | Letter to the SEC | Sep 6, 2022 | — |
| CORRESP | Letter to the SEC | Aug 26, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2022 | — |
| UPLOAD | Letter from the SEC | May 17, 2022 | — |
| CORRESP | Letter to the SEC | May 6, 2022 | — |
| PRER14A | Filing | May 6, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2022 | — |
| CORRESP | Letter to the SEC | Apr 11, 2022 | — |
| PRER14A | Filing | Apr 11, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2022 | — |
| EFFECT | Filing | Jun 29, 2021 | — |
| CERT | Filing | Jun 29, 2021 | — |
| 8-A12B | Filing | Jun 29, 2021 | — |
| CORRESP | Letter to the SEC | Jun 25, 2021 | — |
| CORRESP | Letter to the SEC | Jun 25, 2021 | — |
| CORRESP | Letter to the SEC | Jun 25, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2021 | — |
| DRS | Filing | Apr 21, 2021 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PROK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Winston-Salem, NC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850270
- Former names
- Social Capital Suvretta Holdings Corp. III (until Jul 11, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.